Clinical Trial

A Multicenter and Prospective Study of Screening Retinopathy of Prematurity in China

Study acronym: SChiROP
Completed
View on ClinicalTrials.gov →
Summary
The purpose of the study is to explore the current incidence rate of retinopathy of prematurity (ROP) in China and to explore more appropriate screening criteria for ROP.
Protocol Amendment History 2 changes
critical Completed without a posted recruiting period 2026-08-01
notable Primary completion pushed: 2025-12-14 -> 2026-05-17 2026-08-01
Trial Details
NCT Number NCT06729333
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions Premature Birth of Newborn, Retinopathy of Prematurity (ROP), Low Birthweight Infant
Enrollment 4,841 participants
Start Date 2024-12-03
Primary Completion 2026-05-17 (estimated)
Study Completion 2026-05-17 (estimated)
Updated on ClinicalTrials.gov 2026-07-31